Joel Solomon Zev Schneider - 14 Mar 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role: Chief Operating Officer
Signature: /s/ Erin P. Brennan as attorney-in-fact for Joel Solomon Zev Schneider
Issuer symbol: SLDB
Transactions as of: 14 Mar 2022
Net transactions value: -$33,554
Form type: 4
Filing time: 15 Mar 2022, 17:12:38 UTC
Previous filing: 31 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SLDB	Common Stock	Sale	$16,755	-15,232	-5.7%	$1.10	251,542	14 Mar 2022	Direct	F1, F2
transaction	SLDB	Common Stock	Sale	$16,799	-15,272	-6.1%	$1.10	236,270	14 Mar 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
F2	Reflects a correction as to the number of securities previously reported in Column 5 of Table I due to an arithmetical error.